glp-1 access Why 2026 Will Reshape to Weight Loss Drugs Medicare expands access to GLP-1

Ian's holistic approach to wellbeing prioritises protecting muscle and managing side-effects so that you can build lasting health while losing weight

Glucagon-like peptide-1 (GLP-1) is an incretin known for its anti-obesity effects, and several effective drugs targeting GLP-1 receptors (GLP-1Rs) have recently been developed to treat obesity

Supports gut microbiome balance

The GLP-1 Semaglutide Series of Meal Plans is focused on nutrient density

This may help combat post-meal sluggishness and support steady energy levels throughout the day.* ENCOURAGE NATURAL FAT BURNING & WEIGHT MANAGEMENT* As appetite balance improves, the body may more effectively tap into stored fat for energy

Hill and Holly Wyatt offers a 10-week playbook for stopping GLP1 medications without regaining weight.